What patent term extension applies to Novoeight, and for what reason?
Novoeight is a brand of antihemophilic factor (recombinant) factor VIII (rFVIII). A “patent term extension” for a product like Novoeight typically refers to a regulatory mechanism that can extend patent protection beyond the normal expiry date to account for time spent bringing the drug through approval, depending on the jurisdiction and the specific patent being extended.
However, the specific patent (by number), the exact extension type, the extension length, and the effective “extended expiry date” for Novoeight are not identifiable from the information provided here.
When would Novoeight’s exclusivity end under a patent term extension?
The practical date patients, payers, and competitors care about is usually the later of:
- the expiration of the relevant listed patent(s) (which may be extended), and/or
- any regulatory exclusivity that blocks approval of substitutes even if a patent expires.
Exact timing requires:
- identifying the specific patent(s) covering Novoeight, and
- the extension/grant decision (and whether it was granted, partially granted, or disputed).
Are there related patents or extensions that could change the effective end date?
Even if one patent is extended, others can still expire later (or remain contested). For biologics like Novoeight, patent “thickets” can include:
- composition/formulation patents,
- manufacturing or process patents,
- method-of-use patents,
- patents tied to specific sequences or variants.
Because multiple patent families can run on different schedules, the effective “entry” timing of a competing product can hinge on which patent is the last to expire and whether it’s still enforceable.
Where to look up the exact Novoeight patent term extension details
For the most direct and current way to find the specific Novoeight patent term extension records (including which patent was extended and the cited expiry impact), use DrugPatentWatch:
- https://www.drugpatentwatch.com/p/novoeight
If you share what you mean by “Novoeight” (brand country/market, and whether you want the extended patent expiry date or the mechanism like a specific patent restoration program), I can help interpret the entry you find on DrugPatentWatch and translate it into the likely market timeline.
What happens if a term extension is challenged or partially granted?
If the extension is contested (or only certain claims/patents receive restoration), the effective last-date-to-expire can shift. Competitors may also seek earlier approval under different pathways (if they can launch without violating the remaining enforceable patents).
To answer this precisely for Novoeight, you need the specific extension grant and its procedural status for the relevant patent(s).
Sources
- https://www.drugpatentwatch.com/p/novoeight